Primary Lymphoma of the Eye

Jee Sook Hahn, Chang Ok Suh, Sang Yeul Lee, Woo Ick Yang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Lymphomas in the eye tend to be localized and to have a better prognosis. We reviewed the clinical presentation, treatment outcome and complications of primary lymphomas of the eye at a single institute focusing on the clinical significance of adequate staging and the prognostic value of pathological subtypes. Twenty-four patients with lymphoproliferative lesions of the eye were treated and followed up. The orbit was the most commonly involved site. Twenty-one patients had unilateral diseases and three patients had bilateral. Histological findings revealed 22 malignant lymphomas, one inflammatory pseudotumor and one atypical lymphoid hyperplasia. Using the NCI Working Formulation, most of the malignant lymphomas were primarily low gradediffuse small lymphocytic, 15; diffuse small cleaved, three; diffuse large cell, three; and diffuse mixed, one. The stages of lymphoma were IAE in 21 patients, IBE in one patient, and IIAE in two patients. Twenty-five of the 27 treated eyes remained disease-free during the median follow-up period of 16 months. Nineteen patients received radiotherapy, five patients received chemo-radiotherapy and one patient received only surgical excision. Two patients relapsed outside the treated field. None of the patients complained of severe dry eye syndrome or cataract formation. In conclusion, after complete staging work-up, locally-confined low grade orbital lymphomas can be up to 90% controlled with radiotherapy alone. By contrast, combined treatment is advised in patients with intermediate and high grade lesions.

Original languageEnglish
Pages (from-to)196-201
Number of pages6
JournalYonsei medical journal
Volume39
Issue number3
DOIs
Publication statusPublished - 1998 Jan 1

Fingerprint

Lymphoma
Radiotherapy
Dry Eye Syndromes
Plasma Cell Granuloma
Eye Diseases
Orbit
Non-Hodgkin's Lymphoma
Cataract
Hyperplasia

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hahn, Jee Sook ; Suh, Chang Ok ; Lee, Sang Yeul ; Yang, Woo Ick. / Primary Lymphoma of the Eye. In: Yonsei medical journal. 1998 ; Vol. 39, No. 3. pp. 196-201.
@article{23d60644a1e3476896473a0f3428719d,
title = "Primary Lymphoma of the Eye",
abstract = "Lymphomas in the eye tend to be localized and to have a better prognosis. We reviewed the clinical presentation, treatment outcome and complications of primary lymphomas of the eye at a single institute focusing on the clinical significance of adequate staging and the prognostic value of pathological subtypes. Twenty-four patients with lymphoproliferative lesions of the eye were treated and followed up. The orbit was the most commonly involved site. Twenty-one patients had unilateral diseases and three patients had bilateral. Histological findings revealed 22 malignant lymphomas, one inflammatory pseudotumor and one atypical lymphoid hyperplasia. Using the NCI Working Formulation, most of the malignant lymphomas were primarily low gradediffuse small lymphocytic, 15; diffuse small cleaved, three; diffuse large cell, three; and diffuse mixed, one. The stages of lymphoma were IAE in 21 patients, IBE in one patient, and IIAE in two patients. Twenty-five of the 27 treated eyes remained disease-free during the median follow-up period of 16 months. Nineteen patients received radiotherapy, five patients received chemo-radiotherapy and one patient received only surgical excision. Two patients relapsed outside the treated field. None of the patients complained of severe dry eye syndrome or cataract formation. In conclusion, after complete staging work-up, locally-confined low grade orbital lymphomas can be up to 90{\%} controlled with radiotherapy alone. By contrast, combined treatment is advised in patients with intermediate and high grade lesions.",
author = "Hahn, {Jee Sook} and Suh, {Chang Ok} and Lee, {Sang Yeul} and Yang, {Woo Ick}",
year = "1998",
month = "1",
day = "1",
doi = "10.3349/ymj.1998.39.3.196",
language = "English",
volume = "39",
pages = "196--201",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "3",

}

Hahn, JS, Suh, CO, Lee, SY & Yang, WI 1998, 'Primary Lymphoma of the Eye', Yonsei medical journal, vol. 39, no. 3, pp. 196-201. https://doi.org/10.3349/ymj.1998.39.3.196

Primary Lymphoma of the Eye. / Hahn, Jee Sook; Suh, Chang Ok; Lee, Sang Yeul; Yang, Woo Ick.

In: Yonsei medical journal, Vol. 39, No. 3, 01.01.1998, p. 196-201.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Primary Lymphoma of the Eye

AU - Hahn, Jee Sook

AU - Suh, Chang Ok

AU - Lee, Sang Yeul

AU - Yang, Woo Ick

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Lymphomas in the eye tend to be localized and to have a better prognosis. We reviewed the clinical presentation, treatment outcome and complications of primary lymphomas of the eye at a single institute focusing on the clinical significance of adequate staging and the prognostic value of pathological subtypes. Twenty-four patients with lymphoproliferative lesions of the eye were treated and followed up. The orbit was the most commonly involved site. Twenty-one patients had unilateral diseases and three patients had bilateral. Histological findings revealed 22 malignant lymphomas, one inflammatory pseudotumor and one atypical lymphoid hyperplasia. Using the NCI Working Formulation, most of the malignant lymphomas were primarily low gradediffuse small lymphocytic, 15; diffuse small cleaved, three; diffuse large cell, three; and diffuse mixed, one. The stages of lymphoma were IAE in 21 patients, IBE in one patient, and IIAE in two patients. Twenty-five of the 27 treated eyes remained disease-free during the median follow-up period of 16 months. Nineteen patients received radiotherapy, five patients received chemo-radiotherapy and one patient received only surgical excision. Two patients relapsed outside the treated field. None of the patients complained of severe dry eye syndrome or cataract formation. In conclusion, after complete staging work-up, locally-confined low grade orbital lymphomas can be up to 90% controlled with radiotherapy alone. By contrast, combined treatment is advised in patients with intermediate and high grade lesions.

AB - Lymphomas in the eye tend to be localized and to have a better prognosis. We reviewed the clinical presentation, treatment outcome and complications of primary lymphomas of the eye at a single institute focusing on the clinical significance of adequate staging and the prognostic value of pathological subtypes. Twenty-four patients with lymphoproliferative lesions of the eye were treated and followed up. The orbit was the most commonly involved site. Twenty-one patients had unilateral diseases and three patients had bilateral. Histological findings revealed 22 malignant lymphomas, one inflammatory pseudotumor and one atypical lymphoid hyperplasia. Using the NCI Working Formulation, most of the malignant lymphomas were primarily low gradediffuse small lymphocytic, 15; diffuse small cleaved, three; diffuse large cell, three; and diffuse mixed, one. The stages of lymphoma were IAE in 21 patients, IBE in one patient, and IIAE in two patients. Twenty-five of the 27 treated eyes remained disease-free during the median follow-up period of 16 months. Nineteen patients received radiotherapy, five patients received chemo-radiotherapy and one patient received only surgical excision. Two patients relapsed outside the treated field. None of the patients complained of severe dry eye syndrome or cataract formation. In conclusion, after complete staging work-up, locally-confined low grade orbital lymphomas can be up to 90% controlled with radiotherapy alone. By contrast, combined treatment is advised in patients with intermediate and high grade lesions.

UR - http://www.scopus.com/inward/record.url?scp=0032086414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032086414&partnerID=8YFLogxK

U2 - 10.3349/ymj.1998.39.3.196

DO - 10.3349/ymj.1998.39.3.196

M3 - Article

C2 - 9664823

AN - SCOPUS:0032086414

VL - 39

SP - 196

EP - 201

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 3

ER -